Cite
MLA Citation
J. Albanell et al.. “Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER).” European journal of cancer, vol. 161, 2022, pp. 26–37. http://access.bl.uk/ark:/81055/vdc_100148169381.0x000018